Clofibrate Spofa
Macela, A.
Casopis Lekaru Ceskych 109(30): 700-701
1970
ISSN/ISBN: 0008-7335 PMID: 5428007 Document Number: 25322
Document emailed within 1 workday
Related Documents
Oláh, Z. 1971: Use of Clofibrate SPOFA in the treatment of diabetic retinopathy Ceskoslovenska Oftalmologie 27(5): 315-318Mertz, D.P. 1980: Clofibrate therapy in hypercholesterolemia. Reports on medium-long-term movements of HDL- cholesterol by the action of clofibrate Fortschritte der Medizin 98(45): 1761-1766
Macela, A. 1971: Anti-co Spofa suppositories Casopis Lekaru Ceskych 110(36): 853-854
Semonský, M.; Zikán, V.; Veselá, H. 1973: Cytembena Spofa--a new antineoplastic agent Ceskoslovenska Farmacie 22(7): 313-321
Drobný, M.; Wolfová, E.; Adamkov, J.; Bevilaqua, L.; Fundárek, J.; Pithová, B.; Knéslová, L. 1979: Effectiveness of fenalgin SPOFA in lumboischiadic syndrome Bratislavske Lekarske Listy 71(4): 421-428
Novotný, P. 1972: Pyrvinium Spofa. new drug for the treatment of enterobiasis Casopis Lekaru Ceskych 111(36): 841-842
Grafnetterová, J.; König, J.; Krepelka, J.; Cerný, A.; Klíma, J.; Krebs, V.; Charvát, J. 1985: Problems with the Czechoslovak cytostatic agent Benin Spofa Casopis Lekaru Ceskych 124(26): 820-823
Klener, P.; Donner, L. 1975: Trichlortriethylamine (TS-160 Spofa) in combination chemotherapy of malignant lymphomas Neoplasma 22(1): 55-62
Cernohorský, D.; Král, B.; Hamet, A.; Eliás, J.; Tilser, P.; Rozánek, P.; Sramar, V.; Koudelka, V. 1986: Effect of dihydralazine Spofa on precapillary pulmonary hypertension Vnitrni Lekarstvi 32(9): 855-861
Masáreová, E.; Inczinger, F.; Bózner, A. 1971: Influencing of the isoprenaline necrosis of the myocardium by ATP-Spofa administration Ceskoslovenska Patologie 7(2): 109-112
Janda, J.; Marek, V.; Reitspiesová, K.; Sikut, M.; Korous, J. 1982: Standardized concentration test in school children using Adiuretin Spofa Ceskoslovenska Pediatrie 37(5): 285-288
Havlik, J.; Holý, M. 1976: Erythromycin stearate Spofa--coated tablets for pediatric practice Ceskoslovenska Pediatrie 31(7): 402-404
Navrátil, J.; Hrbek, J.; Dvorák, M. 1972: The therapeutic effect of Stenolon Spofa on female neurotic patients Activitas Nervosa Superior 14(2): 102-103
Petrásek, J.; Cakrtová, M.; Dejmal, V. 1973: Rheologic situation in the vascular bed after infusion of a macromolecular solution (Rheodextran Spofa) Casopis Lekaru Ceskych 112(1): 23-25
Dvorák, K.; Presl, J. 1986: Biological testing of methenmadinone acetate (Superlutin Spofa) in clinical trials Ceskoslovenska Gynekologie 51(9): 714-719
Kovãcsová, B.; Inczinger, F.; Edelsteinovă, S.; Doupovcovă, M. 1972: Effect of K and Mg asparaginate infusions (cardilan Spofa) on LDH isoenzymes in the experimentally injured myocardium Ceskoslovenska Farmacie 21(8): 348-352
Svacinka, P.; Horký, J.; Blahníková, L. 1970: Our experience with long-term therapy of chronic liver diseases using Superanabolon Spofa Vnitrni Lekarstvi 16(12): 1181-1187
Schwartzkopff, W. 1979: Clofibrate banned - what now? Münchener Medizinische Wochenschrift 121(15): 529-533
Navrátil, S.; Knotek, Z.; Manásková, M.; Martínek, J.; Stefan, M.; Soukup, T.; Soukupová, I. 1992: Verification of the usefulness of Estrophan inj. Spofa in the control of reproductive parameters in sows after weaning of piglets Veterinarni Medicina 37(9-10): 509-516
Kudlác, E.; Píchová, D. 1990: The adenohypophyseal response and effect of GnRh (Dirigestran inj. Spofa) administration in cows in the postpartum period Veterinarni Medicina 35(6): 321-330